Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model

Resuscitation

Volumn 80, Issue 9, 2009, Pages 1052-1059

  Jingjun, Lü ^a   Yan, Zhang ^a   WeiJie, ^a   Dongdong, Zhao ^a   Guosheng, Lin ^a   Mingwei, Bao ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Beta adrenergic receptor; Calcium; Cardiopulmonary resuscitation; Catecholamines; Ventricular fibrillation

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ESMOLOL; PLACEBO; RYANODINE RECEPTOR 2; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BOLUS INJECTION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROCARDIOGRAPHY; EPICARDIUM; HEART LEFT VENTRICLE; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RANDOMIZATION; RESUSCITATION; SYSTEMIC CIRCULATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOPULMONARY RESUSCITATION; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; HEART VENTRICLES; MALE; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROPANOLAMINES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION;

EID: 68349112647     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2009.06.003     Document Type: Article

References (37)

1. Killingsworth C.R., Wei C.C., Italia L.J.D., et al. Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival following prolonged VF. Circulation 109 (2004) 2469-2474
2. Klouche k, Weil M.H., Sun S., et al. A comparison of a-methylnorepinephrine, vasopressin and epinephrine for cardiac resuscitation. Resuscitation 57 (2003) 93-100
3. Cammarata G., Weil M.H., Sun S., et al. Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival. Crit Care Med 32 (2004) S440-S443
4. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines formanagement of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 27 (2006) 2099-2140
5. Weiss J., Qu Z., Chen P., et al. The dynamics of cardiac fibrillation. Circulation 112 (2005) 1232-1240
6. Banville I., Chattipakorn N., and Gray R.A. Restitution dynamics during pacing and arrhythmias in isolated pig hearts. J Cardiovasc Electrophysiol 15 (2004) 455-463
7. Hayashi M., Takatsuki S., Maison-Blanche P., et al. Ventricular repolarization restitution properties in patients exhibiting type 1 Brugada electrocardiogram with and without inducible ventricular fibrillation. J Am Coll Cardiol 51 (2008) 1162-1168
8. Pruvot E.J., Katra R.P., Rosenbaum D., et al. Role of calcium cycling versus restitution in the mechanism of repolarization alternans. Circ Res 94 (2004) 1083-1090
9. Goldhaber J.I., Xie L.H., Duong T., et al. Action potential duration restitution and alternans in rabbit ventricular myocytes. The key role of intracellular calcium cycling. Circ Res 96 (2005) 459-466
10. Bao M.W., Zhang J., Huang C., et al. Abnormal intracellular calcium handling underlying T-wave alternans and its hysteresis. Cardiology 108 (2007) 147-156
11. 2+ release. Circ Res 92 (2003) 904-911
12. Kohlhaas M., Zhang T., Seidler T., et al. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ Res 98 (2006) 235-244
13. Grueter C.E., Colbran R.J., Anderson M.E., et al. CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction. J Mol Med 85 (2007) 5-14
14. Khoo M.S.C., Li J., Singh M.V., et al. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Circulation 114 (2006) 1352-1359
15. Jiang H., Zhao D., Cui B., et al. Electrical restitution determined by epicardial contact mapping and surface electrocardiogram: its role in ventricular fibrillation inducibility in swine. JECG 41 (2008) 152-159
16. Lü J., Lin G., Zhao D., et al. Transmural heterogeneity of calcium handling proteins in the mechanism of porcine model of ventricular fibrillation. Chin J Cardiol 36 (2008) 355-359
17. Wan X., Laurita K.R., Pruvot E.J., et al. Molecular correlates of repolarization alternans in cardiac myocytes. J Mol Cell Cardiol 39 (2005) 419-428
18. Narayan S.M. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 47 (2006) 269-281
19. Weiss J.N., Karma A., Shiferaw Y., et al. From pulsus to pulseless: the saga of cardiac alternans. Circ Res 98 (2006) 1244-1253
20. Shiferaw Y., Qu Z., Garfinkel A., et al. Nonlinear dynamics of paced cardiac cells. Ann N Y Acad Sci 1080 (2006) 376-394
21. Mahajan A., Shiferaw Y., Sato D., et al. A rabbit ventricular action potential model replicating cardiac dynamics at rapid heart rates. Biophys J 94 (2008) 392-410
22. Chen P.S., Wu T.J., Ting C.T., et al. A tale of two fibrillations. Circulation 108 (2003) 2298-2303
23. Taggart P., Sutton P., Chalabi Z., et al. Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation 107 (2003) 285-289
24. Chou C., Zhou S., Hayashi1 H., et al. Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts. J Physiol 580 (2007) 895-906
25. Xie L., Sato D., Garfinkel A., et al. Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak. Biophys J 95 (2008) 3100-3110
26. 2+ leak in heart failure. Circ Res 97 (2005) 1314-1322
27. 2+ efflux theory and practice. Prog Biophys Mol Biol 90 (2006) 172-185
28. Zhang T., Maier L.S., Dalton N.D., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92 (2003) 912-919
29. Zhang T., Khoo M.S., Wu Y., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11 (2005) 409-417
30. Wehrens X.H., Lehnart S.E., Reiken S.R., et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304 (2004) 292-296
31. Lehnart S.E., Wehrens X.H., and Marks A.R. Calstabin deficiency, ryanodine receptors, and sudden cardiac death. BBRC 322 (2004) 1267-1279
32. Curran J., Hinton M.J., Rios E., et al. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res 100 (2007) 391-398
33. ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 112 24 Suppl. (2005) IV1-203
34. Holmberg M., Holmgerg S., and Hediu J. Low chance of survival among patients requiring adrenaline (epinephrine) or intubation after out-of-hospital cardiac arrest in Sweden. Resuscitation 54 (2002) 37-45
35. Niemann J.T., and Garner D. Post-resuscitation plasma catecholamines after prolonged arrest in a swine model. Resuscitation 65 (2005) 97-101
36. Gonzalez M., Berg R., Nadkarni V., et al. Left ventricular systolic function and outcome after in-hospital cardiac arrest. Circulation 117 (2008) 1864-1872
37. Tang W., Snyder D., Wang J., et al. One-shock versus three-shock defibrillation protocol significantly improves outcome in a porcine model of prolonged ventricular fibrillation cardiac arrest. Circulation 113 (2006) 2683-2689